Research presented at the American Heart Association's EPI|Lifestyle Scientific Sessions 2026 indicates that waist circumference measurements may provide more accurate heart failure risk assessment than body mass index alone. The study found that systemic inflammation mediates approximately 25-33% of the relationship between central obesity and heart failure development.
The analysis of 1,998 African American adults from the Jackson Heart Study revealed that elevated waist circumference and waist-to-height ratio were consistently associated with increased heart failure risk, while high BMI showed no such association. During the median 6.9-year follow-up period, 112 participants developed heart failure, with those exhibiting higher inflammation levels being more likely to experience the condition.
"This research helps us understand why some people develop heart failure despite having a body weight that seems healthy," said Szu-Han Chen, lead author of the study and a medical student at National Yang Ming Chiao Tung University in Taiwan. The findings suggest that where fat is stored in the body may matter more than total weight for heart failure risk assessment.
The American Heart Association has previously highlighted inflammation's role in cardiovascular disease through resources like the Simple ways to reduce inflammation and protect your heart educational material. According to the Association's 2025 scientific statement on risk-based primary prevention, systemic inflammation can disrupt immune function, damage blood vessels, and promote cardiac scar tissue formation.
Dr. Sadiya S. Khan, chair of the American Heart Association's 2025 Scientific Statement on heart failure prevention, noted that "understanding upstream drivers of heart failure risk including central adiposity is key to recognizing and modifying risk." The Association has launched the Systemic Inflammation Data Challenge to further investigate inflammation's contribution to heart disease.
Clinical implications include potential shifts toward incorporating waist measurements into routine preventive care alongside traditional BMI assessments. The research suggests that monitoring both waist size and inflammation markers could enable earlier identification of at-risk individuals, allowing for targeted prevention strategies before heart failure symptoms manifest.
Study limitations include the lack of heart failure subtype data and the preliminary nature of the findings, which require confirmation through peer-reviewed publication. Future research should examine whether reducing inflammation through targeted interventions can effectively lower heart failure risk in individuals with central obesity.
The American Heart Association maintains strict policies regarding scientific independence, with financial information available here. The organization receives majority funding from non-corporate sources including individual contributions, foundations, and investment earnings.
